How India's Vaccine Renaissance Rests on Innovative & Equitable Solutions

Thanks to its strong R&D ecosystem and smart partnerships, India will be able to play a bigger role in redefining global health equality by making innovative vaccines accessible. The Indian vaccine environment will undergo a dramatic transformation in the next few years due to a spike in investments in innovative vaccine technologies, production platforms, and logistics solutions.

- 

India is renowned for its prowess in scalable and affordable vaccine manufacturing, producing a diverse range of vaccines, including inactivated and live vaccines, protein subunit vaccines, and nextgeneration vaccines like viral vector vaccines, mRNA, and DNA vaccines. It manufactures 50 per cent of the world’s vaccines, and in the last year alone, 4 billion doses of the 8 billion vaccine doses manufactured and distributed globally, were produced in India. Key developers, including global leaders like Serum Institute of India (SII), Bharat Biotech, and Biological E have been instrumental in addressing many globally relevant health challenges and improving preventive healthcare for millions of people.

Improved R&D ecosystem to develop cutting-edge vaccines for global access